Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas
about
Brain tumor classification using AFM in combination with data mining techniques.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomasDifferentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion ModelInterhemispheric Difference Images from Postoperative Diffusion Tensor Imaging of Gliomas.Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation.Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.Non-stem cell origin for oligodendroglioma.Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps.American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13-15, 2009, San Diego, CA.Recent innovations in the management of low-grade gliomas.Glioma grade assessment by using histogram analysis of diffusion tensor imaging-derived maps.
P2860
Q30669767-276223F3-B35A-4E58-868D-B6117DE5C861Q31016200-4C021D2E-F16F-42EC-A68C-06A25D4988C4Q33888366-AA02DDFC-103D-4117-B5DD-01C31B446F3BQ34336127-8A7B939B-4820-4B76-BC85-8A8BEFDA5083Q35419344-38B75AA5-226B-4F10-AFA1-2132EB1730B3Q37246734-90EB6C27-AB9D-429A-81F4-D5E2FF9C23FBQ37395914-0556CBF3-8D74-4284-96D4-9164D9A7292AQ37429908-C8C11DEE-DEE1-4DE3-A661-66BA8F97CE5EQ38663402-6E50A54D-ECDA-46D0-8184-A089E398FF18Q38998271-5A1D522A-FDAE-4A01-844F-BFB6C89D9A24Q39620283-424D408B-3E10-4B4C-A0A7-7698E2901C4DQ40595545-ECEEB964-DE79-4F72-8BBF-9F1C12602F14Q42529944-937B4141-5785-4A02-8704-97F5353B9223Q55462054-739A9C8C-BB00-4942-B9A8-4CEF01711801Q55463849-52FEC659-B672-4DDD-BBB3-158DF3FCD603
P2860
Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apparent diffusion coefficient ...... wly diagnosed grade II gliomas
@en
Apparent diffusion coefficient ...... ly diagnosed grade II gliomas.
@nl
type
label
Apparent diffusion coefficient ...... wly diagnosed grade II gliomas
@en
Apparent diffusion coefficient ...... ly diagnosed grade II gliomas.
@nl
prefLabel
Apparent diffusion coefficient ...... wly diagnosed grade II gliomas
@en
Apparent diffusion coefficient ...... ly diagnosed grade II gliomas.
@nl
P2093
P2860
P356
P1433
P1476
Apparent diffusion coefficient ...... wly diagnosed grade II gliomas
@en
P2093
Colleen McGue
Inas S Khayal
Kathleen R Lamborn
Sarah J Nelson
Scott Vandenberg
Soonmee Cha
Susan M Chang
Tracy R McKnight
P2860
P304
P356
10.1002/NBM.1357
P577
2009-05-01T00:00:00Z